Risk of Reactivation of Latent Tuberculosis in Psoriasis Patients on Biologic Therapies: A Retrospective Cohort from a Tertiary Care Centre in Northern Italy
Psoriatic patients with latent tuberculosis infection and properly treated active tuberculosis need careful management when prescribing modern biological drugs. Although data and guidelines regarding tumour necrosis factor-α inhibitors advise caution and initiation of prophylactic therapy in patient...
Saved in:
Main Authors: | Luca Mastorino (Author), Paolo Dapavo (Author), Mattia Trunfio (Author), Gianluca Avallone (Author), Marco Rubatto (Author), Andrea Calcagno (Author), Simone Ribero (Author), Pietro Quaglino (Author) |
---|---|
Format: | Book |
Published: |
Medical Journals Sweden,
2022-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Seven cancer patients receiving Guselkumab for treatment of moderate-to-severe psoriasis
by: Luca Mastorino, et al.
Published: (2022) -
Efficacy and Safety of Secukinumab in Patients with Plaque Psoriasis and Latent Tuberculosis
by: Simone Ribero, et al.
Published: (2019) -
The Skin Microbiome and Its Role in Psoriasis: A Review
by: Celoria V, et al.
Published: (2023) -
Drug Survival of Anti Interleukin-17 and Interleukin -23 Agents after Adalimumab Failure in Hidradenitis Suppurativa: A Pilot Study
by: Federica Repetto, et al.
Published: (2023) -
Treatment of Advanced Metastatic Melanoma
by: Pietro Quaglino, et al.
Published: (2021)